Capital Partners IV Llc Aisling serves as Executive at Zosano Pharma Corp, where they oversee executive responsibilities. Since joining the company, Capital Partners IV Llc Aisling has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 2, 2019 involved receiving (via award) 689,655 shares valued at $1000.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 2, 2019 | ZSAN | $1000.0K | Award | 689,655 | $1.45 | Discretionary |
Capital Partners IV Llc Aisling currently holds 2,718,226 shares of Zosano Pharma Corp (ZSAN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Partners IV Llc Aisling has been a net neutral trader of ZSAN stock. They have purchased $0 and sold $0 worth of shares.
Capital Partners IV Llc Aisling's most recent insider trade was on Dec 2, 2019, when they sold 689,655 shares at $1.45 per share.
Get notified when new Form 4 filings are submitted